Cargando…
A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
OBJECTIVE: The extracellular volume (ECV) calculated based on contrast-enhanced computed tomography (CT) has been reported as a novel imaging parameter reflecting the morphological change of fibrosis in several parenchymal organs. Our retrospective study assessed the validity of the ECV fraction for...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183286/ https://www.ncbi.nlm.nih.gov/pubmed/37062714 http://dx.doi.org/10.2169/internalmedicine.0410-22 |
_version_ | 1785041923860332544 |
---|---|
author | Kai, Kengo Hiyoshi, Masahide Imamura, Naoya Hamada, Takeomi Yano, Koichi Sato, Yuichiro Sakae, Takehumi Komi, Masanori Nakamura, Takashi Choijookhuu, Narantsog Hishikawa, Yoshitaka Nanashima, Atsushi |
author_facet | Kai, Kengo Hiyoshi, Masahide Imamura, Naoya Hamada, Takeomi Yano, Koichi Sato, Yuichiro Sakae, Takehumi Komi, Masanori Nakamura, Takashi Choijookhuu, Narantsog Hishikawa, Yoshitaka Nanashima, Atsushi |
author_sort | Kai, Kengo |
collection | PubMed |
description | OBJECTIVE: The extracellular volume (ECV) calculated based on contrast-enhanced computed tomography (CT) has been reported as a novel imaging parameter reflecting the morphological change of fibrosis in several parenchymal organs. Our retrospective study assessed the validity of the ECV fraction for diagnosing pancreatic fibrosis and the appropriate imaging condition as the “equilibrium phase”. METHODS: In 27 patients undergoing multiphasic CT and subsequent pancreaticoduodenectomy, we investigated pathological fibrotic changes related to the ECV fraction and conducted analyses using the value obtained by subtracting the equilibrium CT value of the portal vein from that of the abdominal aorta (Ao-PV(equilibrium)) to estimate eligibility of the equilibrium phase. RESULTS: In all patients, the ECV fraction showed a weak positive correlation with the collagenous compartment ratio (r=0.388, p=0.045). All patients were divided into two groups - the high-Ao-PV(equilibrium) group and low-Ao-PV(equilibrium) group - based on the median value. No significant correlation was found in the high-Ao-PV(equilibrium) group, whereas a significant correlation was observed in the low-Ao-PV(equilibrium) group (r=0.566, p=0.035). CONCLUSION: The ECV fraction is a possible predictive factor for histopathological pancreatic fibrosis. In its clinical application, the eligibility of the “equilibrium phase” may affect the diagnostic capability. It will be necessary to verify the imaging conditions in order to improve the accuracy of the diagnosis. |
format | Online Article Text |
id | pubmed-10183286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-101832862023-05-15 A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis Kai, Kengo Hiyoshi, Masahide Imamura, Naoya Hamada, Takeomi Yano, Koichi Sato, Yuichiro Sakae, Takehumi Komi, Masanori Nakamura, Takashi Choijookhuu, Narantsog Hishikawa, Yoshitaka Nanashima, Atsushi Intern Med Original Article OBJECTIVE: The extracellular volume (ECV) calculated based on contrast-enhanced computed tomography (CT) has been reported as a novel imaging parameter reflecting the morphological change of fibrosis in several parenchymal organs. Our retrospective study assessed the validity of the ECV fraction for diagnosing pancreatic fibrosis and the appropriate imaging condition as the “equilibrium phase”. METHODS: In 27 patients undergoing multiphasic CT and subsequent pancreaticoduodenectomy, we investigated pathological fibrotic changes related to the ECV fraction and conducted analyses using the value obtained by subtracting the equilibrium CT value of the portal vein from that of the abdominal aorta (Ao-PV(equilibrium)) to estimate eligibility of the equilibrium phase. RESULTS: In all patients, the ECV fraction showed a weak positive correlation with the collagenous compartment ratio (r=0.388, p=0.045). All patients were divided into two groups - the high-Ao-PV(equilibrium) group and low-Ao-PV(equilibrium) group - based on the median value. No significant correlation was found in the high-Ao-PV(equilibrium) group, whereas a significant correlation was observed in the low-Ao-PV(equilibrium) group (r=0.566, p=0.035). CONCLUSION: The ECV fraction is a possible predictive factor for histopathological pancreatic fibrosis. In its clinical application, the eligibility of the “equilibrium phase” may affect the diagnostic capability. It will be necessary to verify the imaging conditions in order to improve the accuracy of the diagnosis. The Japanese Society of Internal Medicine 2022-04-15 2023-04-15 /pmc/articles/PMC10183286/ /pubmed/37062714 http://dx.doi.org/10.2169/internalmedicine.0410-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Kai, Kengo Hiyoshi, Masahide Imamura, Naoya Hamada, Takeomi Yano, Koichi Sato, Yuichiro Sakae, Takehumi Komi, Masanori Nakamura, Takashi Choijookhuu, Narantsog Hishikawa, Yoshitaka Nanashima, Atsushi A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis |
title | A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis |
title_full | A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis |
title_fullStr | A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis |
title_full_unstemmed | A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis |
title_short | A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis |
title_sort | preliminary pathological evaluation of extracellular volume fraction with contrast-enhanced computed tomography as a novel quantitative parameter of pancreatic fibrosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183286/ https://www.ncbi.nlm.nih.gov/pubmed/37062714 http://dx.doi.org/10.2169/internalmedicine.0410-22 |
work_keys_str_mv | AT kaikengo apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT hiyoshimasahide apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT imamuranaoya apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT hamadatakeomi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT yanokoichi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT satoyuichiro apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT sakaetakehumi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT komimasanori apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT nakamuratakashi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT choijookhuunarantsog apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT hishikawayoshitaka apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT nanashimaatsushi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT kaikengo preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT hiyoshimasahide preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT imamuranaoya preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT hamadatakeomi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT yanokoichi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT satoyuichiro preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT sakaetakehumi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT komimasanori preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT nakamuratakashi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT choijookhuunarantsog preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT hishikawayoshitaka preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis AT nanashimaatsushi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis |